The new entity will house Lupin’s consumer healthcare portfolio, which includes OTC brands such as Softovac, Beplex Forte, Corcium, and Aptivate. The company said the move is aimed at enabling targeted investments, accelerating market expansion, and driving faster growth in the consumer health space.
